MOTPOLY XR

Product NDC: 73289-0064
11-digit product format: 732890064
Labeler code: 73289
Product ID: 73289-0064_3a10a8ff-87ff-a36b-e063-6394a90a473c
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: lacosamide
Dosage form: CAPSULE, EXTENDED RELEASE
Route: ORAL
Labeler: Aucta Pharmaceuticals, Inc.
Application: NDA216185
Marketing category: NDA
Marketing start: 2023-05-05
Substance: LACOSAMIDE
Active strength: 150 mg/1
Pharmacologic classes: Decreased Central Nervous System Disorganized Electrical Activity [PE]
DEA schedule: CV
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N216185-001	MOTPOLY XR	LACOSAMIDE	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04
N216185-002	MOTPOLY XR	LACOSAMIDE	150MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04
N216185-003	MOTPOLY XR	LACOSAMIDE	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	2023-05-04

Orange Book patents#

Current patent rows page 1 of 1 · 18 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N216185-001	11337943	2040-06-05	U-3660	Drug product	2023-08-01
N216185-001	11337943	2040-06-05	U-3954	Drug product	2023-08-01
N216185-001	11883374	2040-06-05	U-3660	Drug product	2024-08-21
N216185-001	11883374	2040-06-05	U-3954	Drug product	2024-08-21
N216185-001	12042474	2040-06-05	U-3660	Drug product	2024-08-21
N216185-001	12042474	2040-06-05	U-3954	Drug product	2024-08-21
N216185-002	11337943	2040-06-05	U-3660	Drug product	2023-08-01
N216185-002	11337943	2040-06-05	U-3954	Drug product	2023-08-01
N216185-002	11883374	2040-06-05	U-3660	Drug product	2024-08-21
N216185-002	11883374	2040-06-05	U-3954	Drug product	2024-08-21
N216185-002	12042474	2040-06-05	U-3660	Drug product	2024-08-21
N216185-002	12042474	2040-06-05	U-3954	Drug product	2024-08-21
N216185-003	11337943	2040-06-05	U-3660	Drug product	2023-08-01
N216185-003	11337943	2040-06-05	U-3954	Drug product	2023-08-01
N216185-003	11883374	2040-06-05	U-3660	Drug product	2024-08-21
N216185-003	11883374	2040-06-05	U-3954	Drug product	2024-08-21
N216185-003	12042474	2040-06-05	U-3660	Drug product	2024-08-21
N216185-003	12042474	2040-06-05	U-3954	Drug product	2024-08-21

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 66 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N216185-001	MOTPOLY XR	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216185-002	MOTPOLY XR	150MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216185-003	MOTPOLY XR	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	2023-05-04	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216185-001	MOTPOLY XR	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216185-002	MOTPOLY XR	150MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216185-003	MOTPOLY XR	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	2023-05-04	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N216185-001	MOTPOLY XR	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N216185-002	MOTPOLY XR	150MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N216185-003	MOTPOLY XR	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	2023-05-04	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N216185-001	MOTPOLY XR	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N216185-002	MOTPOLY XR	150MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N216185-003	MOTPOLY XR	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	2023-05-04	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N216185-001	MOTPOLY XR	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N216185-002	MOTPOLY XR	150MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N216185-003	MOTPOLY XR	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	2023-05-04	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N216185-001	MOTPOLY XR	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N216185-002	MOTPOLY XR	150MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N216185-003	MOTPOLY XR	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	2023-05-04	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N216185-001	MOTPOLY XR	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N216185-002	MOTPOLY XR	150MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N216185-003	MOTPOLY XR	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	2023-05-04	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N216185-001	MOTPOLY XR	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N216185-002	MOTPOLY XR	150MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N216185-003	MOTPOLY XR	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	2023-05-04	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N216185-001	MOTPOLY XR	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N216185-002	MOTPOLY XR	150MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N216185-003	MOTPOLY XR	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	2023-05-04	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N216185-001	MOTPOLY XR	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N216185-002	MOTPOLY XR	150MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N216185-003	MOTPOLY XR	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	2023-05-04	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N216185-001	MOTPOLY XR	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N216185-002	MOTPOLY XR	150MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N216185-003	MOTPOLY XR	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	2023-05-04	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N216185-001	MOTPOLY XR	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N216185-002	MOTPOLY XR	150MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N216185-003	MOTPOLY XR	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	2023-05-04	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N216185-001	MOTPOLY XR	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N216185-002	MOTPOLY XR	150MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N216185-003	MOTPOLY XR	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	2023-05-04	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N216185-001	MOTPOLY XR	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2023-05-04	`8072bd15b7f6…`

Observed Orange Book patent history#

Patent history page 1 of 6 · 231 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N216185-001	11337943	2040-06-05	U-3660	Drug product	2023-08-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216185-001	11337943	2040-06-05	U-3954	Drug product	2023-08-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216185-001	11883374	2040-06-05	U-3660	Drug product	2024-08-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216185-001	11883374	2040-06-05	U-3954	Drug product	2024-08-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216185-001	12042474	2040-06-05	U-3660	Drug product	2024-08-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216185-001	12042474	2040-06-05	U-3954	Drug product	2024-08-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216185-002	11337943	2040-06-05	U-3660	Drug product	2023-08-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216185-002	11337943	2040-06-05	U-3954	Drug product	2023-08-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216185-002	11883374	2040-06-05	U-3954	Drug product	2024-08-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216185-002	11883374	2040-06-05	U-3660	Drug product	2024-08-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216185-002	12042474	2040-06-05	U-3954	Drug product	2024-08-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216185-002	12042474	2040-06-05	U-3660	Drug product	2024-08-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216185-003	11337943	2040-06-05	U-3660	Drug product	2023-08-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216185-003	11337943	2040-06-05	U-3954	Drug product	2023-08-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216185-003	11883374	2040-06-05	U-3954	Drug product	2024-08-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216185-003	11883374	2040-06-05	U-3660	Drug product	2024-08-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216185-003	12042474	2040-06-05	U-3954	Drug product	2024-08-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N216185-003	12042474	2040-06-05	U-3660	Drug product	2024-08-21	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216185-001	11337943	2040-06-05	U-3660	Drug product	2023-08-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216185-001	11337943	2040-06-05	U-3954	Drug product	2023-08-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216185-001	11883374	2040-06-05	U-3660	Drug product	2024-08-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216185-001	11883374	2040-06-05	U-3954	Drug product	2024-08-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216185-001	12042474	2040-06-05	U-3660	Drug product	2024-08-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216185-001	12042474	2040-06-05	U-3954	Drug product	2024-08-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216185-002	11337943	2040-06-05	U-3660	Drug product	2023-08-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216185-002	11337943	2040-06-05	U-3954	Drug product	2023-08-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216185-002	11883374	2040-06-05	U-3954	Drug product	2024-08-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216185-002	11883374	2040-06-05	U-3660	Drug product	2024-08-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216185-002	12042474	2040-06-05	U-3954	Drug product	2024-08-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216185-002	12042474	2040-06-05	U-3660	Drug product	2024-08-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216185-003	11337943	2040-06-05	U-3660	Drug product	2023-08-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216185-003	11337943	2040-06-05	U-3954	Drug product	2023-08-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216185-003	11883374	2040-06-05	U-3954	Drug product	2024-08-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216185-003	11883374	2040-06-05	U-3660	Drug product	2024-08-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216185-003	12042474	2040-06-05	U-3954	Drug product	2024-08-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N216185-003	12042474	2040-06-05	U-3660	Drug product	2024-08-21	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N216185-001	11337943	2040-06-05	U-3660	Drug product	2023-08-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N216185-001	11337943	2040-06-05	U-3954	Drug product	2023-08-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N216185-001	11883374	2040-06-05	U-3660	Drug product	2024-08-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N216185-001	11883374	2040-06-05	U-3954	Drug product	2024-08-21	`6a471c1ec25d…`

Additional Listing Data#

Finished product: Yes
Brand name base: MOTPOLY XR
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LACOSAMIDE	150 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
563KS2PQY5	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 6 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2637018	Internal RxNorm lookup
2637025	Internal RxNorm lookup
2637027	Internal RxNorm lookup
2637030	Internal RxNorm lookup
2637032	Internal RxNorm lookup
2637035	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
fb8235b4-4cd3-6f22-e053-6294a90a545c	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fac83aa9-21ef-4152-b501-369c0bc4765b	Product name	1	20231010
c8c500b5-16db-e0e3-fdf1-c683d7be70e3	Product name	3	20161117

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
73289-0064-2	MOTPOLY XR	60 in 1 BOTTLE, PLASTIC	CAPSULE, EXTENDED RELEASE	60		5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
73289-0064	MOTPOLY XR (LACOSAMIDE) CAPSULE, EXTENDED RELEASE [AUCTA PHARMACEUTICALS, INC.]	4	Current NDC, 1 package rows	20241103_fb8235b4-4cd3-6f22-e053-6294a90a545c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
MOTPOLY XR	LACOSAMIDE	Aucta Pharmaceuticals, Inc.	fb8235b4-4cd3-6f22-e053-6294a90a545c	2025-07-16	Warnings, Adverse reactions	Exact identifier application applno (NDA): 216185 application number: NDA216185 ndc (product): 73289-0064

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
563KS2PQY5	LACOSAMIDE	175481-36-4	LACOSAMIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
2637018	lacosamide 100 MG 24HR Extended Release Oral Capsule	PSN	fb8235b4-4cd3-6f22-e053-6294a90a545c	5
2637027	lacosamide 150 MG 24HR Extended Release Oral Capsule	PSN	fb8235b4-4cd3-6f22-e053-6294a90a545c	5
2637032	lacosamide 200 MG 24HR Extended Release Oral Capsule	PSN	fb8235b4-4cd3-6f22-e053-6294a90a545c	5
2637025	Motpoly XR 100 MG 24HR Extended Release Oral Capsule	PSN	fb8235b4-4cd3-6f22-e053-6294a90a545c	5
2637030	Motpoly XR 150 MG 24HR Extended Release Oral Capsule	PSN	fb8235b4-4cd3-6f22-e053-6294a90a545c	5
2637035	Motpoly XR 200 MG 24HR Extended Release Oral Capsule	PSN	fb8235b4-4cd3-6f22-e053-6294a90a545c	5
2637025	24 HR lacosamide 100 MG Extended Release Oral Capsule [Motpoly]	SBD	fb8235b4-4cd3-6f22-e053-6294a90a545c	5
2637030	24 HR lacosamide 150 MG Extended Release Oral Capsule [Motpoly]	SBD	fb8235b4-4cd3-6f22-e053-6294a90a545c	5
2637035	24 HR lacosamide 200 MG Extended Release Oral Capsule [Motpoly]	SBD	fb8235b4-4cd3-6f22-e053-6294a90a545c	5
2637018	24 HR lacosamide 100 MG Extended Release Oral Capsule	SCD	fb8235b4-4cd3-6f22-e053-6294a90a545c	5
2637027	24 HR lacosamide 150 MG Extended Release Oral Capsule	SCD	fb8235b4-4cd3-6f22-e053-6294a90a545c	5
2637032	24 HR lacosamide 200 MG Extended Release Oral Capsule	SCD	fb8235b4-4cd3-6f22-e053-6294a90a545c	5
2637025	24 HR Motpoly 100 MG Extended Release Oral Capsule	SY	fb8235b4-4cd3-6f22-e053-6294a90a545c	5
2637030	24 HR Motpoly 150 MG Extended Release Oral Capsule	SY	fb8235b4-4cd3-6f22-e053-6294a90a545c	5
2637035	24 HR Motpoly 200 MG Extended Release Oral Capsule	SY	fb8235b4-4cd3-6f22-e053-6294a90a545c	5
2637018	lacosamide 100 MG 24HR Extended Release Oral Capsule	SY	fb8235b4-4cd3-6f22-e053-6294a90a545c	5
2637027	lacosamide 150 MG 24HR Extended Release Oral Capsule	SY	fb8235b4-4cd3-6f22-e053-6294a90a545c	5
2637032	lacosamide 200 MG 24HR Extended Release Oral Capsule	SY	fb8235b4-4cd3-6f22-e053-6294a90a545c	5
2637025	Motpoly XR 100 MG 24HR Extended Release Oral Capsule	SY	fb8235b4-4cd3-6f22-e053-6294a90a545c	5
2637030	Motpoly XR 150 MG 24HR Extended Release Oral Capsule	SY	fb8235b4-4cd3-6f22-e053-6294a90a545c	5
2637035	Motpoly XR 200 MG 24HR Extended Release Oral Capsule	SY	fb8235b4-4cd3-6f22-e053-6294a90a545c	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Sample	Exclude flag	Status
73289-0064-2	73289006402	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (73289-0064-2)	2023-05-05	No	No	Current